Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 49

1.

Is there a causal relation between the administration of gadolinium based contrast media and the development of nephrogenic systemic fibrosis (NSF)?

Thomsen HS, Morcos SK, Dawson P.

Clin Radiol. 2006 Nov;61(11):905-6. No abstract available.

PMID:
17018301
[PubMed - indexed for MEDLINE]
2.

[Nephrogenic systemic fibrosis].

Cavallini L, Abaterusso C, Bedogna V, Pertica N, Loschiavo C, Lupo A.

G Ital Nefrol. 2008 Jan-Feb;25(1):14-20. Review. Italian.

PMID:
18264914
[PubMed - indexed for MEDLINE]
3.

[Nephrogenic systemic fibrosis and use of MR contrast media].

Christiansen RE, Sviland L, Sekse I, Svarstad E.

Tidsskr Nor Laegeforen. 2009 Jan 29;129(3):180-2. doi: 10.4045/tidsskr.09.33117. Review. Norwegian.

PMID:
19180161
[PubMed - indexed for MEDLINE]
Free Article
4.

The role of gadolinium in triggering nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy.

Solomon GJ, Rosen PP, Wu E.

Arch Pathol Lab Med. 2007 Oct;131(10):1515-6. Review. No abstract available.

PMID:
17922586
[PubMed - indexed for MEDLINE]
5.

[Nephrogenic systemic fibrosis: another problem for patients with chronic renal failure].

Michelet PR, Chopard CS, Martin PY, Vallée JP.

Rev Med Suisse. 2008 Mar 5;4(147):576-8, 580. Review. French.

PMID:
18402015
[PubMed - indexed for MEDLINE]
6.

Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy: a primer for radiologists.

Prasad SR, Jagirdar J.

J Comput Assist Tomogr. 2008 Jan-Feb;32(1):1-3. doi: 10.1097/RCT.0b013e31805d08ee. Review.

PMID:
18303280
[PubMed - indexed for MEDLINE]
7.

Nephrogenic systemic fibrosis: a review and exploration of the role of gadolinium.

Cowper SE.

Adv Dermatol. 2007;23:131-54. Review.

PMID:
18159899
[PubMed - indexed for MEDLINE]
8.

Nephrogenic systemic fibrosis and its association with gadolinium exposure during MRI.

Issa N, Poggio ED, Fatica RA, Patel R, Ruggieri PM, Heyka RJ.

Cleve Clin J Med. 2008 Feb;75(2):95-7, 103-4, 106 passim. Review.

PMID:
18290353
[PubMed - indexed for MEDLINE]
9.

Extracellular Gd-CA: differences in prevalence of NSF.

Thomsen HS, Marckmann P.

Eur J Radiol. 2008 May;66(2):180-3. doi: 10.1016/j.ejrad.2008.01.024. Epub 2008 Mar 14. Review.

PMID:
18342468
[PubMed - indexed for MEDLINE]
10.

Nephrogenic systemic fibrosis: more questions and some answers.

Morcos SK, Thomsen HS.

Nephron Clin Pract. 2008;110(1):c24-31; discussion c32. doi: 10.1159/000151228. Epub 2008 Aug 7. Review.

PMID:
18688172
[PubMed - indexed for MEDLINE]
11.

[Nephrogenic fibrosing dermopathy or nephrogenic systemic fibrosis? What do we know and what do we have to learn?].

Ortega LM, Contreras G, Lenz O.

Nefrologia. 2009;29(2):109-17. doi: 10.3265/Nefrologia.2009.29.2.4842.en.full. Review. Spanish.

PMID:
19396315
[PubMed - indexed for MEDLINE]
Free Article
12.

Gadolinium use in patients with kidney disease: a cause for concern.

Perazella MA, Rodby RA.

Semin Dial. 2007 May-Jun;20(3):179-85. Review.

PMID:
17555477
[PubMed - indexed for MEDLINE]
13.

Gadolinium-associated nephrogenic systemic fibrosis: the need for nephrologists' awareness.

Canavese C, Mereu MC, Aime S, Lazzarich E, Fenoglio R, Quaglia M, Stratta P.

J Nephrol. 2008 May-Jun;21(3):324-36. Review.

PMID:
18587720
[PubMed - indexed for MEDLINE]
14.

Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: a critical review.

Idée JM, Port M, Medina C, Lancelot E, Fayoux E, Ballet S, Corot C.

Toxicology. 2008 Jun 27;248(2-3):77-88. doi: 10.1016/j.tox.2008.03.012. Epub 2008 Mar 22. Review.

PMID:
18440117
[PubMed - indexed for MEDLINE]
15.

Nephrogenic systemic fibrosis: history and epidemiology.

Thomsen HS.

Radiol Clin North Am. 2009 Sep;47(5):827-31, vi. doi: 10.1016/j.rcl.2009.05.003. Review.

PMID:
19744597
[PubMed - indexed for MEDLINE]
16.

Nephrogenic systemic fibrosis: chronic imaging findings and review of the medical literature.

Weigle JP, Broome DR.

Skeletal Radiol. 2008 May;37(5):457-64. doi: 10.1007/s00256-008-0464-1. Epub 2008 Mar 7. Review.

PMID:
18324398
[PubMed - indexed for MEDLINE]
17.

Gadolinium-enhanced magnetic resonance imaging, renal failure and nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy.

Stratta P, Canavese C, Aime S.

Curr Med Chem. 2008;15(12):1229-35. Review.

PMID:
18473815
[PubMed - indexed for MEDLINE]
18.

Nephrogenic systemic fibrosis: epidemiology update.

Marckmann P.

Curr Opin Nephrol Hypertens. 2008 May;17(3):315-9. doi: 10.1097/MNH.0b013e3282f4b605. Review.

PMID:
18408485
[PubMed - indexed for MEDLINE]
19.

Gadolinium-based contrast media and the development of nephrogenic systemic fibrosis in patients with renal insufficiency.

Chewning RH, Murphy KJ.

J Vasc Interv Radiol. 2007 Mar;18(3):331-3. Review. Erratum in: J Vasc Interv Radiol. 2007 Nov;18(11):1463.

PMID:
17377176
[PubMed - indexed for MEDLINE]
20.

MRI gadolinium-based contrast agents. Radiologists beware!

Goullé JP, Cattanéo A, Saussereau E, Mahieu L, Guerbet M, Lacroix C.

Ann Pharm Fr. 2009 Sep;67(5):335-9. doi: 10.1016/j.pharma.2009.06.002. Epub 2009 Jul 23. Review.

PMID:
19695369
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk